How to Diagnose Pulmonary Hypertension on Echo?

Echocardiography diagnoses pulmonary hypertension not by producing a single definitive number but by building a probability estimate from multiple converging signs. The cornerstone measurement is the peak velocity of tricuspid regurgitation, which allows calculation of pressure gradients across the right heart. But that velocity alone is not the whole picture. Current guidelines layer it with structural and Doppler findings from the right ventricle, pulmonary artery, and inferior vena cava to classify the likelihood of pulmonary hypertension as low, intermediate, or high, and that probability determines whether a patient should proceed to the gold-standard test: right heart catheterization.

The Probability Framework

Rather than treating a single pressure cutoff as the answer, contemporary guidelines use a tiered system built around the peak tricuspid regurgitation velocity (TRV). If TRV exceeds 3.4 m/s, the echocardiographic probability of pulmonary hypertension is considered high regardless of other findings. Below that threshold, the sonographer looks for additional signs drawn from three categories: the ventricles (category A), the pulmonary artery (category B), and the inferior vena cava and right atrium (category C). Signs from at least two of these categories must be present to raise the probability from low to intermediate or high.¹

The specific velocity thresholds break down as follows. When TRV is 2.8 m/s or below and no other echo signs of pulmonary hypertension are visible, the probability is low. When TRV is 2.8 m/s or below but other echo signs are present, or when TRV falls in the 2.9 to 3.4 m/s range without other signs, the probability is intermediate. And when TRV is between 2.9 and 3.4 m/s with additional echo signs present, or above 3.4 m/s with or without other signs, the probability is high.² This layered approach helps avoid over-reliance on a single Doppler measurement, which can be technically difficult to obtain cleanly in some patients.

Estimating Pulmonary Artery Systolic Pressure

The central hemodynamic estimate on echo is the pulmonary artery systolic pressure (PASP). It comes from measuring the peak velocity of the tricuspid regurgitation jet using continuous-wave Doppler, then applying the simplified Bernoulli equation to convert that velocity into a pressure gradient between the right ventricle and right atrium. To that gradient you add an estimate of right atrial pressure (RAP), which is usually derived from inferior vena cava size and how much it collapses with breathing. The sum gives you estimated PASP.³

In a large patient population, this approach correlates well with invasive measurements. One study of over 1,500 patients found a correlation coefficient of 0.87 between Doppler-estimated and catheter-measured systolic pulmonary artery pressure, with an average bias of only about 2 mmHg. Using a cutoff of 36 mmHg, echo had a sensitivity of 87%, a specificity of 79%, and an overall accuracy of 85% for identifying pulmonary hypertension.⁴ These numbers are encouraging, but they describe group-level performance. For any individual patient, the estimate can drift substantially from the catheter value.

Right Ventricular Size and Shape

Beyond pressure estimation, echocardiography reveals how the right ventricle is handling its increased workload. In significant pulmonary hypertension, the right ventricle dilates. The interventricular septum, which normally curves toward the right, flattens or even bows toward the left ventricle, giving the left ventricle a characteristic D-shape when viewed in the short-axis window.⁵ The timing of that septal flattening carries diagnostic information. A D-shape visible during systole (especially end-systole) points to right ventricular pressure overload, which is the hallmark of pulmonary hypertension. A D-shape seen mainly in diastole instead suggests volume overload, a different mechanism altogether.⁶

Right ventricular wall thickness is another visual clue. Chronic pressure overload triggers hypertrophy of the free wall, which normally measures under 5 mm. Right atrial dilation and a pulmonary artery diameter exceeding 25 mm round out the structural signs that push the probability assessment upward.²

Measuring Right Ventricular Function

Identifying pulmonary hypertension is one thing; knowing how the right ventricle is coping is equally important for prognosis and treatment decisions. Two conventional echo measures dominate clinical practice. TAPSE (tricuspid annular plane systolic excursion) tracks how far the base of the right ventricle moves toward the apex during contraction, capturing the longitudinal component of right ventricular function. Fractional area change (FAC) takes a broader view, measuring the percentage change in the right ventricular cavity area between diastole and systole, which incorporates both longitudinal and transverse contraction.

In a study comparing both measures against the gold-standard right ventricular ejection fraction obtained by cardiac MRI, FAC correlated more strongly with ejection fraction than TAPSE did (r = 0.81 versus r = 0.63). FAC was also better at predicting severely reduced ejection fraction, with an area under the curve of 0.91 compared to 0.77 for TAPSE. The advantage was especially clear in patients with a more severe hemodynamic profile, likely because FAC captures the transverse contraction component that TAPSE misses.⁷ Pooled data from patients with pulmonary hypertension showed the difference in their correlation with invasive hemodynamics was not statistically significant, so in routine practice both measures remain useful and complementary.⁸

Speckle-tracking strain takes functional assessment a step further. Right ventricular free-wall longitudinal strain, measured by tracking myocardial deformation patterns, is significantly reduced in pulmonary hypertension and independently predicts mean pulmonary artery pressure and pulmonary vascular resistance.⁹ In critically ill patients with pulmonary arterial hypertension, strain-based indices including right ventricular free-wall strain and right atrial conduit strain were significantly associated with one-year mortality, with strain-to-pressure ratios showing a protective effect when the right ventricle maintained reasonable contractile reserve relative to its afterload.¹⁰

Inferior Vena Cava and Right Atrial Pressure

The inferior vena cava (IVC) serves as a window into right atrial pressure, which is needed to complete the PASP calculation. Standard practice measures the IVC diameter near its junction with the right atrium and observes how much it collapses with a sniff (the respiratory collapse index). A dilated IVC that barely collapses during inspiration signals elevated right atrial pressure. One study of 102 catheterized patients found that an IVC diameter cutoff of 2.0 cm predicted right atrial pressure above or below 10 mmHg with a sensitivity of 73% and specificity of 85%, and a collapsibility cutoff of 40% performed similarly.¹¹

This method has real-world pitfalls. The diaphragm can compress the IVC in certain patients, making it appear smaller than it actually is and leading to underestimation of right atrial pressure. One group found that measuring the IVC at a site free from diaphragmatic compression nearly doubled the sensitivity for detecting elevated pressures.¹² In congenital heart disease patients, a newer analysis found that a collapse index below 60% outperformed the conventional approach.¹³ In children, absolute IVC diameter varies with age, so the percentage of collapse during inspiration matters more than any fixed size threshold.¹⁴

Pulmonary Artery Doppler Patterns

Pulsed-wave Doppler in the right ventricular outflow tract (RVOT) provides another layer of information that does not depend on having a usable tricuspid regurgitation jet. The acceleration time (AT), meaning the interval from the onset of flow to peak velocity, reflects right ventricular afterload. An AT below 70 ms suggests markedly elevated afterload, 70 to 100 ms suggests mild to moderate elevation, and above 100 ms is relatively normal.¹⁵ The shape of the Doppler envelope itself is informative: a mid-systolic notch, where flow briefly decelerates and then re-accelerates, is highly specific for increased pulmonary vascular resistance and reduced compliance. A late-systolic notch carries similar implications.

Pulmonary vascular resistance (PVR) can also be estimated by combining tricuspid regurgitation velocity with the velocity-time integral of flow through the RVOT. In patients with congenital heart disease and pulmonary hypertension, this ratio correlated strongly with catheter-derived PVR (r = 0.90). A ratio of 0.14 predicted PVR above 6 Wood units with a sensitivity of about 97% and specificity of 93%.¹⁶ In patients with advanced lung disease, echo-derived PVR models were accurate to within about 2 Wood units in over three-quarters of cases, though precision was moderate and limits of agreement remained wide.¹⁷ PVR estimation on echo is useful for trending over time and for flagging severe elevations, but it is not precise enough to replace catheterization when exact numbers drive treatment choices.

Pericardial Effusion as a Warning Sign

Fluid around the heart appears in a surprisingly large proportion of patients with severe pulmonary arterial hypertension. In one cohort, pericardial effusion was present in more than half of patients with severe disease.¹⁸ This is not incidental. Pericardial effusion in pulmonary hypertension signals right heart failure, and its presence independently predicts worse outcomes. In multivariable models that included hemodynamic and clinical variables, pericardial effusion and right atrial enlargement remained independent predictors of death or need for transplantation.¹⁹ Larger effusions in particular tracked with worse hemodynamics and poorer exercise tolerance.²⁰

This makes the pericardial space worth inspecting deliberately during every pulmonary hypertension echo, not just glancing at it in passing. A new or worsening effusion in a patient already known to have pulmonary arterial hypertension should prompt concern about decompensation.

How Accurate Is Echo Compared to Catheterization?

Echo performs well as a screening tool but has limitations as a precision instrument. Group averages of echo-estimated and catheter-measured pressures tend to match closely, with minimal overall bias. One carefully designed comparison found nearly identical mean values for mean pulmonary artery pressure, left atrial pressure, and cardiac output, with tight confidence intervals around the bias. But the individual-patient spread was wide: the limits of agreement for mean pulmonary artery pressure ranged from roughly +19 to -18 mmHg, meaning any given patient’s echo estimate could be off by nearly 20 mmHg in either direction.²¹

This gap between excellent average agreement and wide individual scatter explains why echo cannot replace catheterization for confirming the diagnosis or making precise treatment decisions. Echo tells you whether pulmonary hypertension is likely and roughly how severe it appears. Catheterization tells you the actual numbers. In practice, echo stratifies who needs the invasive test; it does not eliminate the need for it.

Some of the individual-level error stems from technical limitations. Obtaining a clean tricuspid regurgitation jet is not always possible, especially in patients with large body habitus or hyperinflated lungs. When the unenhanced signal is poor, contrast microspheres can improve the spectral Doppler envelope in a meaningful number of patients, though they add little when the unenhanced signal is already clear or tricuspid regurgitation is more than mild.²²

Separating Pulmonary Hypertension Subtypes on Echo

Identifying elevated pulmonary pressures is only part of the challenge. The next clinical question is why the pressures are elevated, because treatment differs dramatically depending on the cause. One of the most common distinctions is between pulmonary arterial hypertension (a disease of the pulmonary vasculature itself) and pulmonary hypertension driven by left heart disease, particularly heart failure with preserved ejection fraction (HFpEF). Echo can help separate the two. Patients with PH due to HFpEF tend to have higher left ventricular mass, larger left atria, and relatively smaller right ventricles at end-diastole compared to those with pulmonary arterial hypertension. A clinical-echocardiographic scoring model incorporating diabetes history, atrial fibrillation, left atrial area, right ventricular end-diastolic area, and left ventricular mass index was able to predict PH-HFpEF in a multivariate analysis.²³

In practice, left-sided findings on echo are often the biggest clue. A patient with elevated pulmonary pressures, a dilated left atrium, grade II or III diastolic dysfunction, and elevated E/e’ ratio almost certainly has left-heart-driven pulmonary hypertension. A patient with a normal-sized left atrium, normal diastolic filling, and severe right ventricular dilation is more likely to have pulmonary arterial hypertension or chronic thromboembolic disease. The distinction is not always clear-cut, especially in older patients who may have both left-heart disease and intrinsic pulmonary vascular disease, but a systematic echo evaluation of both sides of the heart provides the initial roadmap.

Exercise Stress Echocardiography

Resting echo may miss early or exercise-induced pulmonary hypertension. Some patients have borderline or normal pressures at rest that climb sharply with exertion, a pattern that can explain unexplained exercise intolerance. Exercise stress echocardiography allows real-time measurement of tricuspid regurgitation velocity during or immediately after exercise. This is particularly relevant in conditions like systemic sclerosis, where patients may have resting pulmonary pressures in the “grey zone” (intermediate probability) that become clearly abnormal under stress.²⁴ Technically, exercise echo is more demanding than resting studies because the patient is moving, heart rate is elevated, and the acoustic window may worsen with breathing effort. But in experienced hands it adds a dimension that resting echo simply cannot provide.

Three-Dimensional Echocardiography

The right ventricle has an irregular, crescent-shaped geometry that two-dimensional imaging struggles to capture fully. Any single 2D plane inevitably underestimates or oversimplifies its true volume. Real-time three-dimensional echocardiography overcomes much of this limitation. Using validated algorithms, 3D echo can measure right ventricular volumes and ejection fraction with accuracy approaching that of cardiac MRI.²⁵ This is especially valuable in serial monitoring of patients with pulmonary hypertension, where detecting subtle changes in right ventricular size or function can prompt earlier treatment adjustments. The trade-off is that 3D acquisition requires good image quality and specialized software, so availability varies across echo labs.

Practical Approach for Readers

If you are learning to assess pulmonary hypertension on echo, the sequence to internalize is straightforward. Start by obtaining the best possible tricuspid regurgitation signal, using multiple windows including the right ventricular inflow view and the apical four-chamber, and measure peak velocity carefully. If the signal is suboptimal, consider agitated saline or contrast enhancement. From TRV, calculate the pressure gradient and combine it with your IVC-based estimate of right atrial pressure for PASP. Then step back from the numbers and look at the morphology: right ventricular dilation, wall thickness, septal flattening, right atrial size, pulmonary artery diameter, and pericardial effusion. Check the RVOT Doppler pattern for a shortened acceleration time or mid-systolic notching. Measure TAPSE, FAC, and ideally right ventricular free-wall strain. Finally, evaluate the left heart to start distinguishing the likely cause of elevated pressures.

Each of these elements is imperfect in isolation. The diagnostic power of echo in pulmonary hypertension comes from integration, from combining a pressure estimate with structural changes, functional markers, and ancillary findings into a coherent probability picture. No single measurement makes or breaks the diagnosis. When the pieces converge toward the same answer, you can be confident in your probability assignment. When they conflict, the discrepancies themselves are informative and often point directly to where the catheterization data will matter most.